2019
DOI: 10.1016/j.jacc.2019.07.084
|View full text |Cite
|
Sign up to set email alerts
|

Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2019
2019
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 30 publications
0
2
0
1
Order By: Relevance
“…ST segment monitoring technology embedded in conventionally indicated ICDs when tested in a randomized cross‐over study suggested a reduction in the time from the onset of ischemia to presentation to hospital 198,199 . The AngelMed Guardian system (Angel Medical Systems, Eatontown, New Jersey) is approved for use in the United States for patients with prior acute coronary syndrome (ACS) who remain at high risk for recurrent ACS.…”
Section: Comorbiditiesmentioning
confidence: 99%
“…ST segment monitoring technology embedded in conventionally indicated ICDs when tested in a randomized cross‐over study suggested a reduction in the time from the onset of ischemia to presentation to hospital 198,199 . The AngelMed Guardian system (Angel Medical Systems, Eatontown, New Jersey) is approved for use in the United States for patients with prior acute coronary syndrome (ACS) who remain at high risk for recurrent ACS.…”
Section: Comorbiditiesmentioning
confidence: 99%
“…ST segment monitoring technology embedded in conventionally indicated ICDs when tested in a randomized cross-over study suggested a reduction in the time from the onset of ischemia to presentation to hospital ( Gibson et al., 2019 , Holmes et al., 2019 ). The AngelMed Guardian system (Angel Medical Systems, Eatontown, New Jersey) is approved for use in the United States for patients with prior acute coronary syndrome (ACS) who remain at high risk for recurrent ACS.…”
Section: Comorbiditiesmentioning
confidence: 99%
“…По данным перекрёстных РКИ, оценивающих эффективность технологии мониторинга сегмента ST, которая интегрирована в стандартные ИКДаппараты, в экспериментальной группе получено явное клиническое преимущество, т.к. наблюдается сокращение времени от начала возникновения ишемии до обращения в стационар (Gibson 2019, Holmes DR Jr 2019. Система AngelMed Guardian (Angel Medical Systems, Итонтаун, Нью Джерси) одобрена к применению в США у пациентов с первичным ОКС и с высоким риском повторного ОКС.…”
Section: амбулаторный этапunclassified